2023年6月29日,

。分享这篇文章提供的新闻分享这篇文章坦佩亚利桑那。,2023年6月29日/ GT医疗技术,inc .的提供者GammaTile®治疗患者的治疗中可操作的脑瘤,宣布促进肖恩·布朗总统的位置。马修·比作目前总裁兼首席执行官将继续在他作为首席执行官的角色。肖恩·布朗,GT总统医疗技术自从加入GT医疗技术,公司在2022年5月,布朗先生担任首席商务官,负责领导销售、营销、客户业务和人力资源。在巴蒂尔的领导下,GammaTile疗法已经扩大到超过90医院和医疗机构在美国。罗经航向,布朗先生制定战略方向和协作的基础销售和营销之间的对齐而强调病人和以客户为中心的方法。布朗先生在他的新角色,将监督临床试验,研究和开发,融资,同时保持当前的责任。“我们的团队致力于提高意识GammaTile疗法。我们有机会来驱动采用这个神奇的治疗脑瘤患者需要更好的选择,”肖恩·布朗说,总统GT的医疗技术。 "With over 27 years of commercial and general management experience in North America and Europe, we are pleased to announce the promotion of Mr. Brown to the leadership role of President," said Matthew Likens, CEO of GT Medical Technologies. "His accessible leadership style and sharp analytical approach will help us fulfill the company mission to improve the lives of patients with brain tumors. We are confident he will continue to help us meet company growth goals and expand GammaTile Therapy adoption so that more patients can benefit from this game-changing brain tumor radiation treatment." Before joining GT Medical Technologies, Mr. Brown was the president and general manager of North America for Itamar Medical, a NASDAQ-listed company that was acquired by ZOLL Medical in December 2021. Previously, Mr. Brown has held leadership roles in a host of other medical device companies including AngioDynamics, AGA Medical, St. Jude Medical, Topera and Abbott. About GT Medical Technologies, Inc. Driven to raise the standard of care and improve the lives of patients with brain tumors, a team of brain tumor specialists formed GT Medical Technologies. FDA-cleared GammaTile Surgically Targeted Radiation Therapy (STaRT) is for patients with all types of newly diagnosed malignant and recurrent brain tumors. This "one-and-done" treatment eliminates the need for one to six weeks of daily external beam radiation therapy, allowing patients to go about their daily lives, without the burden of additional trips to the hospital or clinic for ongoing treatment. Since its full market release in the United States in March 2020, GammaTile has been offered in more than 90 hospitals, with more centers being added each month. For more information, visit www.gtmedtech.com and follow @GammaTile on Twitter and LinkedIn Media contact: